Literature DB >> 18564100

Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.

Kunihiko Kodama1, Masanobu Hokama, Kenji Kawaguchi, Yuichiro Tanaka, Kazuhiro Hongo.   

Abstract

Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma composed of CD30-positive cells. Anaplastic lymphoma kinase (ALK) -1 positive ALCL frequently involves both lymph nodes and extranodal sites. While primary extranodal involvement of ALK-1 negative ALCL is rare, this case is unique in that it is a case of primary ALK-1 negative ALCL of the brain. A 79-year-old man presented with dementia-like symptoms. Neuroimaging revealed a well-enhanced mass in the left parieto-occipital region. The tumor was excised and histological diagnosis of primary ALK-1-negative ALCL was made. Primary ALK-1-negative ALCL in this case showed aggressive clinical behavior and fatal outcome. It is of great importance to avoid any delay in reaching an accurate diagnosis, as even primary ALCL of the brain is too seldom suspected clinically.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18564100     DOI: 10.1111/j.1440-1789.2008.00935.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  10 in total

1.  Primary CNS T-cell Lymphomas: A Clinical, Morphologic, Immunophenotypic, and Molecular Analysis.

Authors:  Madhu P Menon; Alina Nicolae; Hillary Meeker; Mark Raffeld; Liqiang Xi; Armin G Jegalian; Douglas C Miller; Stefania Pittaluga; Elaine S Jaffe
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Beyond B-cell lymphomas: a case of optic nerve anaplastic large cell lymphoma in a HIV positive patient.

Authors:  S L Coleman; B N Setty; J N M Tan; O Sakai
Journal:  Clin Neuroradiol       Date:  2013-08-17       Impact factor: 3.649

3.  Primary anaplastic large cell lymphoma in the dura of the brain: case report and prediction of a favorable prognosis.

Authors:  Min-Kyung Kim; Chang-Ho Cho; Woo-Jung Sung; Hun-Mo Ryoo; Ho-Jun Lee; Sung-Won Youn; Kwan-Kyu Park
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

Review 4.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

Review 5.  Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Authors:  Ashley E Aaroe; Kathryn S Nevel
Journal:  Curr Oncol Rep       Date:  2019-03-27       Impact factor: 5.945

6.  18F-FDG PET/CT imaging findings in anaplastic large cell lymphoma, a rare subtype of lymphoma.

Authors:  Yanping Jiang; Lijuan Wang; Wenlan Zhou; Jiamei Gu; Ying Tian; Ye Dong; Lilan Fu; Hu-Bing Wu
Journal:  Cancer Imaging       Date:  2020-01-10       Impact factor: 3.909

7.  Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement.

Authors:  Shino Magaki; Radha Satyadev; Zesheng Chen; Kathryn S Yung; Harry V Vinters; Marsha C Kinney; Jonathan W Said
Journal:  Brain Tumor Pathol       Date:  2021-11-18       Impact factor: 3.298

8.  Lymphomatous Meningitis From Anaplastic Lymphoma Kinase+ Anaplastic Large T-Cell Lymphoma Treated With Lorlatinib: A Case Report.

Authors:  Smitha Mellacheruvu; Mark N Sayegh; R Alejandro Sica; Haiying Cheng; Maria Laureana Santos-Zabala; Jacob H Gebrael; Ulrich Hermanto; Norman L Rosen
Journal:  JCO Precis Oncol       Date:  2022-02

Review 9.  Anaplastic Large Cell Lymphoma: Molecular Pathogenesis and Treatment.

Authors:  Xin-Rui Zhang; Pham-Ngoc Chien; Sun-Young Nam; Chan-Yeong Heo
Journal:  Cancers (Basel)       Date:  2022-03-24       Impact factor: 6.639

10.  Clinical presentation of anaplastic large-cell lymphoma in the central nervous system.

Authors:  Masashi Nomura; Yoshitaka Narita; Yasuji Miyakita; Makoto Ohno; Shintaro Fukushima; Takashi Maruyama; Yoshihiro Muragaki; Soichiro Shibui
Journal:  Mol Clin Oncol       Date:  2013-04-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.